Pharmaceuticals News and Research

RSS

Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment

Sanofi (EURONEXT: SAN and NASDAQ: SNY) and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announce today a collaboration to co-develop and co-commercialize asset TEV’574, currently in Phase 2b clinical trials for the treatment of Ulcerative Colitis and Crohn's Disease, two types of inflammatory bowel disease.

From Sanofi 4 Oct 2023

Stem cell-derived islet cell therapy shows promise for type 1 diabetes

Six adults with type 1 diabetes (T1D) treated with stem cell-derived islet cells (VX-880) have shown improved blood sugar control with three participants achieving insulin independence, according to new research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct).

3 Oct 2023

Could seaweeds be the superfood and medicine of the future?

Researchers consolidate the diverse nutritional and medicinal benefits of seaweeds, touting their potential in food, nutraceuticals, and pharmaceuticals. The study also highlights challenges and opportunities in industrial applications, calling for more research to optimize extraction and refinement processes.

2 Oct 2023

Study reveals new insights into how the immune system prevents autoimmunity

Researchers at Stanford University School of Medicine, Yale University School of Medicine, and the Hospital for Special Surgery Research Institute have uncovered new details about how the immune system prevents the production of antibodies that can recognize and damage the body's own, healthy tissues.

29 Sep 2023

Self‐administration of investigational intranasal spray may be a new option to treat rapid heartbeat

A fast-acting medication delivered as a nasal spray may someday allow patients with intermittent rapid heartbeats to treat it themselves as soon as they develop symptoms, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

27 Sep 2023

SRI spins off a biosciences platform that accelerates drug discovery

SRI International announced today it is spinning off Synfini, a biosciences platform that accelerates the process by which pharmaceutical and other companies can design, synthesize, and bring to market molecules for drug development.

26 Sep 2023

One health wake-up call: London's river data highlights environmental perils

The largest-ever spatiotemporal monitoring of chemicals/contaminants of emerging concern (CECs) in London waterways.

26 Sep 2023

UMMC transplant team performs second pig heart transplant on patient with end-stage heart disease

After world's first successful transplant in 2022, also performed at the University of Maryland Medical Center (UMMC), this groundbreaking transplant team performed second pig heart transplant on patient deemed ineligible for traditional heart transplant.

25 Sep 2023

When you think about your health, don’t forget your eyes

I vividly remember that late Friday afternoon when my eye pressure spiked and I staggered on foot to my ophthalmologist's office as the rapidly thickening fog in my field of vision shrouded passing cars and traffic lights.

22 Sep 2023

KFF Health News' 'What the Health?': Countdown to shutdown

Health and other federal programs are at risk of shutting down, at least temporarily, as Congress races toward the Oct. 1 start of the fiscal year without having passed any of its 12 annual appropriations bills.

21 Sep 2023

Study reveals link between oral health and survival among head and neck cancer patients

An international study has revealed strong associations between oral health and survival among people diagnosed with head and neck cancer.

19 Sep 2023

Tufts Lyme Disease Initiative receives $7M in grants to advance research to next level

Researchers at the Tufts Lyme Disease Initiative recently received grants totaling more than $7 million to build on an already impressive array of discoveries that Tufts' teams have made to combat tick-borne diseases.

19 Sep 2023

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

19 Sep 2023

Why the CDC has recommended new covid boosters for all

Everyone over the age of 6 months should get the latest covid-19 booster, a federal expert panel recommended Tuesday after hearing an estimate that universal vaccination could prevent 100,000 more hospitalizations each year than if only the elderly were vaccinated.

13 Sep 2023

Doctors must address Parkinson’s patients’ hidden burden of stigma, report says

Even the best treatment approaches for Parkinson's disease are inadequate if they do not address patients' feelings of social rejection, isolation, loneliness and other psychosocial effects of stigma, according to a report from experts specializing in Parkinson's and other movement disorders.

12 Sep 2023

Global health experts to meet at UN to discuss 100 days mission for pandemic preparedness

The Science Summit at UNGA in New York will play host to a stellar line-up of global health experts, who will come together on Thursday 14th September to set out the concrete actions leaders need to make the 100 Days Mission for Pandemic Preparedness a reality.

12 Sep 2023

Experimental insomnia treatment may help prevent opioid relapse

A good night's sleep has many proven health benefits, and a new Scripps Research study suggests one more: preventing opioid relapse.

6 Sep 2023

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy.

5 Sep 2023

Experts call for changes to how drugs are tested and labeled for people with obesity

A new opinion piece published in Health Affairs Forefront raises questions around current approaches to assess drug safety and effectiveness in people with obesity.

5 Sep 2023

Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC.

From Optibrium Ltd. 31 Aug 2023

Previous
1
...
40
41
42
43
44
45
46
...
1290
Next

Pharmaceuticals News and Research

Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment

Stem cell-derived islet cell therapy shows promise for type 1 diabetes

Could seaweeds be the superfood and medicine of the future?

Study reveals new insights into how the immune system prevents autoimmunity

Self‐administration of investigational intranasal spray may be a new option to treat rapid heartbeat

SRI spins off a biosciences platform that accelerates drug discovery

One health wake-up call: London's river data highlights environmental perils

UMMC transplant team performs second pig heart transplant on patient with end-stage heart disease

When you think about your health, don’t forget your eyes

KFF Health News' 'What the Health?': Countdown to shutdown

Study reveals link between oral health and survival among head and neck cancer patients

Tufts Lyme Disease Initiative receives $7M in grants to advance research to next level

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Why the CDC has recommended new covid boosters for all

Doctors must address Parkinson’s patients’ hidden burden of stigma, report says

Global health experts to meet at UN to discuss 100 days mission for pandemic preparedness

Experimental insomnia treatment may help prevent opioid relapse

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

Experts call for changes to how drugs are tested and labeled for people with obesity

Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering

Event guide: World ADC London eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring